{
    "clinical_study": {
        "@rank": "11649", 
        "arm_group": {
            "arm_group_label": "Surgical intervention", 
            "arm_group_type": "Experimental", 
            "description": "Patients will undergo standard resection and gastrointestinal anastomosis and will then have reinforcement of the anastomosis with MatriStem PSM. Patients undergoing esophagectomy, PG or TG will be evaluated with one routine postoperative contrast swallow study at post-operative day #4-10."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if implanting MatriStem will lower the risk of one of\n      the more common complications after stomach or esophagus surgery."
        }, 
        "brief_title": "Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material", 
        "condition": "Esophageal Adenocarcinoma", 
        "condition_browse": {
            "mesh_term": "Adenocarcinoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient 18 years of age or older\n\n          -  Pathologically confirmed Gastric, Gastroesophageal Junction (GEJ) or Esophageal,\n             adenocarcinoma at MSKCC (biopsy may be performed at other institutions but slides\n             must be confirmed at MSKCC, as is routine care at our institution)\n\n          -  Patient undergoing any resection requiring an anastomosis to the esophagus for\n             curative intent. Including but not limited to esophagectomy or total gastrectomy.\n\n          -  Subject is willing to provide written informed consent\n\n          -  Subject is willing and able to comply with the follow-up regimen\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating women\n\n          -  Intraoperative evidence of metastatic or locally-unresectable disease\n\n          -  Patients with known sensitivity or allergy to porcine materials.\n\n          -  Patients undergoing any resection requiring an anastomosis to the esophagus for\n             palliative intent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01970306", 
            "org_study_id": "13-178"
        }, 
        "intervention": {
            "arm_group_label": "Surgical intervention", 
            "description": "All esophageal anastomoses will be reinforced circumferentially with ACell MatriStem PSM.", 
            "intervention_name": "MatriStem PSM", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Esophageal Reinforcement", 
            "ACell MatriStem", 
            "13-178"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "link": {
            "description": "Memorial Sloan-Kettering Cancer Center", 
            "url": "http://www.mskcc.org/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Vivian Strong, MD", 
                    "phone": "212-639-5056"
                }, 
                "contact_backup": {
                    "last_name": "Nabil P. Rizk, MD", 
                    "phone": "212-639-8357"
                }, 
                "facility": {
                    "address": {
                        "city": "Basking Ridge", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Memoral Sloan Kettering Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Vivian Strong, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Vivian Strong, MD", 
                    "phone": "212-639-5056"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Memorial Sloan Kettering Cancer Center"
                }, 
                "investigator": {
                    "last_name": "Vivian Strong, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective Phase II Trial to Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material", 
        "overall_contact": {
            "last_name": "Vivian Strong, MD", 
            "phone": "212-639-5056"
        }, 
        "overall_contact_backup": {
            "last_name": "Nabil P. Rizk, MD", 
            "phone": "212-639-8357"
        }, 
        "overall_official": {
            "affiliation": "Memorial Sloan-Kettering Cancer Center", 
            "last_name": "Vivian Strong, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Anastomotic leak will be assessed by clinical observation and one postoperative contrast study (thin-barium of Gastrografin swallow)", 
            "measure": "rates of anastomotic leak.", 
            "safety_issue": "Yes", 
            "time_frame": "up to 10 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01970306"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will be evaluated in the outpatient clinic and will be assigned a dysphagia score from 0-4 by the RSA. Patients reporting symptoms consistent with stricture will be evaluated with radiographic contrast swallow study or endoscopy.", 
                "measure": "stricture formation clinically and by determination of dysphagia score", 
                "safety_issue": "No", 
                "time_frame": "90 days postoperatively"
            }, 
            {
                "description": "Data for cost metrics will be collected postoperatively through POD90 (+/- 14 days). These include metrics such as Length of Stay, Readmission, Complications, Reoperation and Total Hospital Bill.", 
                "measure": "cost metrics", 
                "safety_issue": "No", 
                "time_frame": "postoperatively (+/- 14 days)"
            }
        ], 
        "source": "Memorial Sloan-Kettering Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "ACell Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Memorial Sloan-Kettering Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}